首页|重度颈动脉狭窄CT灌注成像输入方法分析及治疗策略

重度颈动脉狭窄CT灌注成像输入方法分析及治疗策略

扫码查看
目的 研究重度颈动脉狭窄CT灌注成像(CTP)的输入方法及治疗策略.方法 纳入2020年6月至2021年6月期间我院收治的90例重度颈动脉狭窄(CAS)患者作为研究对象,所有患者均经数字减影血管造影(DSA)确诊.患者均进行CTP检查,按照CTP输入不同分为健侧组、患侧组以及基底组.对比三种输入方式下脑血容量(CBV)、脑血流量(CBF)、达峰时间(TTP)、平均通过时间(MTT)以及延迟时间(DT)等灌注值.根据CTP灌注值选取无症状患者进行治疗,按随机数字表法将无症状患者平均分为两组,对照组采用阿司匹林联合阿托伐他汀治疗,观察组采用吲哚布芬片联合阿托伐他汀治疗,观察两组患者的治疗效果和不良反应.随访1年,观察两组患者不良事件发生情况.结果 三种输入方式下重度CAS患者CBV、TTP对比差异无统计学意义(P>0.05);基底组和健侧组灌注参数对比均无差异(P>0.05);患侧组CBF、MTT以及DT与其他两组对比均有差异(P<0.05).治疗前两组患者FIB、D-D、TM以及TAFI水平对比,差异无统计学意义(P>0.05);治疗后观察组FIB、D-D、TM以及TAFI水平低于对照组,差异有统计学意义(P<0.05).两组患者不良反应包括恶心呕吐、消化道出血以及腹痛.观察组发生率仅为8.33%,明显低于对照组的37.50%,差异有统计学意义(P<0.05).随访1年后,观察组不良事件发生率和卒中发生率均低于对照组,差异有统计学意义(P<0.05).结论 对于重度颈动脉狭窄的患者,选择健侧大脑中动脉和基底动脉对CTP灌注参数影响较小,且吲哚布芬治疗效果较好,能尽可能降低患者的卒中发生率,安全性更高.
Analyze the CT Perfusion Imaging Approaches and Treatment Schemes for Severe Carotid Artery Stenosis Patients
Objective To analyze the computed tomography perfusion imaging(CTP)approaches and treatment schemes for severe carotid artery stenosis patients.Methods 90 severe carotid artery stenosis(CAS)patients treated from June 2020 to June 2021 in our hospital were selected as research subjects.All of patients were confirmed by digital subtraction angiography(DSA)and then examined by CTP.According to the different CTP approaches,patients were divided into unaffected side group,affected side group and basilar group.The cerebral blood volume(CBV),cerebral blood flow(CBF),time to peak(TTP),mean transit time(MTT)and delay time(DT)were compared.According to the perfusion parameters,the asymptomatic patients were chosen and randomly divided into control group(Aspirin and Atorvastatin)and observation group(indobufen tablets and Atorvastatin).Patients were followed for one year.Treatment effects and adverse drug reactions were counted.Results There were no significant differences about CBV and TTP values for severe CAS patients based on three perfusion approaches(P>0.05);the perfusion parameters between basilar group and unaffected side group were not significantly different(P>0.05);CBF,MTT and DT values for affected side group were found to be statistically significant with the other two groups(P<0.05);before therapy,fibrinogen(FIB),D-dimer(D-D),thrombomodulin(TM)and thrombin-activatable fibrinolysis inhibitor(TAFI)levels between observation group and control group showed no statistically significant difference(P>0.05);after treatment,FIB,D-D,TM and TAFI levels in the observation group were lower than those of control group,with statistically significant difference(P<0.05);the incidences of adverse reactions like nausea,vomiting,gastrointestinal bleeding and stomachache in the observation group(8.33%)were lower than those of control group(37.50%),with statistically significant difference(P<0.05);during one-year follow-up visit,the occurrences of adverse events and cerebral stroke in the observation group were lower than those of control group,with statistically significant difference(P<0.05).Conclusion CTP parameters are less affected by the middle cerebral artery and basilar artery;meanwhile,indobufen tablets can better reduce the occurrences of cerebral stroke and increase the treatment effects and safety for severe carotid artery stenosis patients.

Severe Carotid Artery StenosisCT Perfusion imagingIndobufenAtorvastatinStroke

张慎和、郭菲、刘冬、王宝志、刘建辉

展开 >

衡水市中医医院影像科(河北衡水 053000)

三河燕郊福合第一医院(河北廊坊 065201)

张家口市第一医院神经内科(河北张家口 075041)

衡水市第六人民医院影像科(河北衡水 053000)

衡水市中医医院碎石科(河北衡水 053000)

展开 >

重度颈动脉狭窄 CT灌注成像 吲哚布芬 阿托伐他汀 卒中

河北省卫生健康委医学科学研究课题计划

20221509

2024

中国CT和MRI杂志
北京大学深圳临床医学院 北京大学第一医院

中国CT和MRI杂志

CSTPCD
影响因子:1.578
ISSN:1672-5131
年,卷(期):2024.22(2)
  • 20